Basic and Diluted Net Loss Per Share (Tables)

9 Months Ended

Sep. 30, 2018

Schedule of Common Equivalent Shares were Excluded From Diluted Net Loss Per Share Calculation because their Inclusion would have been Anti-Dilutive

The following common equivalent shares were excluded from the diluted net loss per share calculation because their inclusion would have been anti-dilutive:

	As of September 30,
	2018		2017
Stock options		1,836,671		2,469,553
Convertible senior notes		3,411,199		—
Non-vested performance-based restricted stock units		93,362		—
Non-vested market-based restricted stock units		11,877		286,000
Non-vested restricted stock units		417,209		286,000
Total		5,770,318		3,041,553

Schedule of Common Stock Reserved

The amount of such shares of the Company’s common stock reserved for these purposes at September 30, 2018 is as follows:

	Number of Shares
Stock options issued and outstanding		1,836,671
Additional shares available for grant under equity plans		2,174,253
Total		4,010,924